Platelets and ectonucleotidases

Platelets

Volumn 5, Issue 3, 1994, Pages 121-129

  Bakker, W W ^a   Poelstra, K ^a   Barradas, M A ^b   Mikhailidis, D P ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; APYRASE; ENDOTHELIUM DERIVED RELAXING FACTOR; NUCLEOTIDASE; PROSTANOID; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; CELL INTERACTION; DIABETES MELLITUS; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FATTY ACID BLOOD LEVEL; HEMOSTASIS; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PLACENTA INSUFFICIENCY; PRIORITY JOURNAL; REVIEW; SPECIES DIFFERENCE; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOSIS;

EID: 0028201041     PISSN: 09537104     EISSN: None     Source Type: Journal    
DOI: 10.3109/09537109409005523     Document Type: Review

References (99)

1. Platelets
2. Blood coagulation and the inflammatory response
3. Cellular adhesion; GPIIb-IIIa as a prototype adhesion receptor
4. Blood coagulation factors V and VIII; structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders
5. Regulatory effects of adenosine and adenine nucleotides on oxygen radical responses of neutrophils
6. The neural endothelial interactions in control of local blood flow
7. Endothelium derived relaxing factor and coronary vasospasm
8. Modulation of endothelial cell hemostatic properties by tumor necrosis factor
9. Selfregulation of procoagulant events on the endothelial cell surface
10. Interleukin 1 stimulates platelet activity factor production in cultured human endothelial cells
11. Thrombosis and inflammation as multicellular processes: pathophysiologic significance of transcellular metabolism
12. Platelet-mononuclear cell co-generation in eicosanoid and leukotriene production
13. Platelet derived growth factor: structure function and roles in normal and transformed cells
14. Multicellular control mechanisms of platelet reactivity: New concepts in thromboregulation
15. Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis
16. Prostaglandins, platelet aggregation and haemostasis
17. The hydrolysis of extracellular adenine nucleotides by cultured endothelial cells from pig aorta: Feed forward inhibition of adenosine production at the cell surface
18. Evidence that the ADP hydrolysis in human cells is related to thrombogenic potential
19. A membrane-bound enzyme in rabbit aorta capable of inhibiting adenosine-diphosphate-induced platelet aggregation
20. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
21. Endothelium-derived factor (EDRF) and nitric oxide (NO) I Physiology, pharmacology and pathophysiological implications
22. Identification in vitro of and endothelial cell surface cofactor for antithrombin III: Parallel studies with isolated perfused rat hearts and microcarrier cultures of bovine endothelium
23. Recovery of endothelial cell prostacyclin production after inhibition by low doses of aspirin
24. Estimated rate of prostacyclin secretion into the circulation of normal man
25. Prostacyclin and thromboxane in diabetes
26. Does human placenta produce prostacyclin?
27. The human placental antiaggregating factor is neither prostacyclin nor a prostacyclin metabolite
28. Platelet aggregation inhibiting activity of human placental chorioepithelial brush border membrane vesicles
29. Nucleotide metabolism by endothelium
30. Inhibition of platelet function by an aspirin sensitive endothelial cell ADP-ase: Thromboregulation by endothelial cells
31. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: Blockade of aggregation and secretion by an aspirin-insensitive mechanism
32. Further evidence that haemostasis depends more on ADP than on thromboxane A2 in the rat [Abstract]
33. The anatomical distribution of ADPase activity in the rabbit aorta
34. The adenylate kinase of human plasma erythrocytes and platelets in relation to the degradation of adenosine diphosphate in plasma
35. Partial-purification and characterization of an ADP-phosphohydrolase from human plasma
36. Assay kinetics and properties of plasma adenosine diphosphatase. The relationship to acid and alkaline phosphatase and variations in disease
37. Subcellular localization and properties of adenosine diphosphatase activity in human polymorphonuclear leucocytes
38. Studies on the kinetic properties and subcellular localization of adenosine diphosphatase activity in human peripheral blood lymphocytes
39. Reactions of 14C-ADP and 14C-ATP with washed platelets from rabbits
40. Subcellular localization of adenosine diphosphatase in cultured pig arterial endothelial cells
41. Metabolism of adenosine nucleotides by ectoenzymes of vascular endothelial and smooth muscle cells in culture
42. Demonstration of a novel ecto-enzyme on human erythrocytes, capable of degrading ADP and of inhibiting ADP-induced platelet aggregation
43. Metabolism of adenine nucleotides in human blood
44. Demonstration of antithrombotic activity of glomerular adenosine diphosphatase
45. Extracellular ATP in T-lymphocyte activation: Possible role in effector functions
46. Platelet enhancement of O2- responses in stimulated human neutrophils. Identification of platelet factor as adenine nucleotide
47. Modulation of anti-Thy I nephritis in the rat by adenine nucleotides: Evidence for an anti-inflammatory role for nucleotidases
48. Human platelets mediate iron release from transferrin by adenine nucleotide dependent and -independent mechanism
49. Glomerulonephritis induced by monoclonal anti-thy I.I antibodies: A sequential histological and ultrastructural study in the rat
50. Intraglomerular platelet aggregation and experimental glomerulonephritis
51. Adriamycin induced decrease of ATP-ase activity in the glomerular basement membrane of the rat kidney is mediated by oxygen free radical species
52. Adenosine; an endogenous inhibitor of neutrophil-mediated injury to endothelial cells
53. Adenosine receptor on human basophils: modulation of histamine release
54. Attenuation of anti-thy glomerulonephritis in the rat: Anti-inflammatory activity of platelet inhibiting pharmacha
55. Cytochemical demonstration of ATP-ase activity in the rat kidney basement using the cerium-based method
56. Endotoxin induced intraplacental thrombotic tendency and decreased vascular ADP-ase in the pregnant rat
57. Survey of the occurence of adenosine polyphosphatase in extracellular matrix of rat tissues. A cytochemical investigation
58. The rat liver ecto-ATP-ase is also a canalicular bile acid transport protein
59. Antithrombotic activity of glomerular adenosine diphosphatase in the glomerular basement membrane of the rat kidney
60. Decreased ATP-ase activity in adriamycin nephrosis is independent of proteinuria
61. A modified cerium-based histochemical method for detection of experimentally induced ATP-ase impairment in glomeruli of the rat kidney. J. Histochem
62. Platelet survival and function in rats with enhanced thrombotic tendency
63. Intraglomerular thrombotic tendency and glomerular ADP-ase. Unilateral impairment of ADP-ase elicits a proaggregatory microenvironment in experimental glomerulonephritis
64. Adriamycin affects glomerular renal function: evidence for the involvement of oxygen radicals
65. 5'Nucleotidase. Distribution of 5'nucleotidase in tissue of rat and mouse
66. Demonstration of glomerular ATP/ADP-ase in the glomerular filtration barrier of the human kidney [Abstract]
67. Relevance of adenine nucleotidases in the glomerular filtration barrier
68. Purine catabolism in polymorphonuclear neutrophils. Phorbol myristate acetate-induced accumulation of adenosine owing to inactivation of extracellular released adenosine deaminase
69. Different interactions of platelets with arterial and venous coronary bypass vessels
70. Adenine nucleotides and the endothelium
71. A novel receptor operated Ca2+ permeable channel activated by ATP in smooth muscle
72. The effects of ATP on endothelium
73. Endothelium dependant and endothelium-independent effects of adenosine diphosphate in renovascular hypertension
74. Decreased prostacyclin production by placental cells in culture from pregnancies complicated by fetal growth retardation. Br J
75. Adenosine diphosphate degrading activity in placenta
76. Membranes exert indirect negative control on phospholipase A2 (PLA2) in human placenta
77. Anti-aggregatory effects of physiological concentrations of adenosine in human whole blood as assessed by filtragometry
78. ADPase activity in human maternal and cord blood: possible evidence for a placenta—specific vascular protective mechanism
79. An investigation into the effects of bacterial lipopolysaccharide on human platelets
80. N-formylmethionine-leucine-phenylalanine (fMLP), a bacterial chemotactic peptide, stimulates platelet shape change in human whole blood
81. Partial separation of platelet and placental adenosine receptors from adenosine A2-like binding protein
82. Definition of subclasses of adenosine receptors associated with adenylate cyclase: interaction of adenosine analogs with inhibitory A1 receptors and stimulatory A2 receptors
83. The effect of non-esterified fatty acids on vascular ADP—degrading enzyme activity
84. Effect of streptozotocin—induced diabetes on the metabolism of ADP, AMP and adenosine in the pulmonary circulation of rat isolated lung
85. Effect of non-esterified fatty acids on the stability of prostacyclin activity
86. Albumin, haemostasis and cardiovascular disease
87. Use of radioligands in the identification, classification, and study of adenosine receptors
88. Dipyridamole inhibition of adenosine metabolism in human blood
89. Effect of dipyridamole—like compound (R-E 244) on aggregation and cyclic AMP accumulation in human platelets
90. Role of cyclic AMP in adenosine inhibition of intracellular calcium rise in human platelets. Comparison of adenosine effects on thrombin- and epinephrine-induced platelet stimulation
91. Inhibition of ADP-induced responses in human platelets by agents elevating the cyclic AMP level: comparison of aggregation and shape change
92. Exogenous GTP increases cyclic GMP and inhibits thrombin-induced aggregation of washed human platelets: comparison with ATP, adenosine and guanosine
93. Cardiovascular effects of adenosine
94. The disappearance of adenosine from blood and platelet suspension in relation to platelet cyclic AMP content
95. Platelet aggregation induced by the endoperoxide analogue U46619 is inhibited by polymorphonuclear leukocyte ADPase activity
96. Platelet antiaggregating and haemodynamic effects of adenosine and prostaglandin E1
97. Adenosine spares platelets during cardiopulmonary bypass in man without causing systemic vasodilatation
98. 5'-ethylcarboxamidoadenosine: a potent inhibitor of human platelet aggregation